U-Blot® Research Grade Anti-Human IL17A (CAT-2200)Cat. No. WA2020$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human IL17A (CAT-2200)Cat. No. WA2020
U-Blot® Research Grade Anti-Human IL17A (ABM59)Cat. No. WA2019
U-Blot® Research Grade Anti-Human IL15R (DR50402)Cat. No. WA2018
U-Blot® Research Grade Anti-Human IL15 (DISC0280)Cat. No. WA2017
U-Blot® Research Grade Anti-Human IL13 (MEDI7836)Cat. No. WA2016
U-Blot® Research Grade Anti-Human IL13 (M1295)Cat. No. WA2015
U-Blot® Research Grade Anti-Human IL13 (IMA-026)Cat. No. WA2014
U-Blot® Research Grade Anti-Human IL13 (H2L6)Cat. No. WA2013
U-Blot® Research Grade Anti-Human IL13 (GSK679586)Cat. No. WA2012
U-Blot® Research Grade Anti-Human IL13 (CNTO-5825)Cat. No. WA2011
U-Blot® Research Grade Anti-Human IL13 (CNTO 607)Cat. No. WA2010
U-Blot® Research Grade Anti-Human IL13 (C836)Cat. No. WA2009